I was playing with ChatGPT and asked it about Adalta Ltd. It gave a reference to AD-712 as being:
"AD-712 is a drug candidate being developed by Adalta Ltd for the treatment of glioblastoma, which is a type of aggressive brain cancer. Glioblastoma is associated with a poor prognosis, with few effective treatment options currently available.
AD-712 is an i-body drug candidate that targets a protein called CXCR4, which is involved in the progression of glioblastoma. By targeting CXCR4, AD-712 has the potential to inhibit the growth and spread of glioblastoma cells.
Preclinical studies of AD-712 have demonstrated promising results, including the ability to significantly reduce the growth of glioblastoma tumors in mouse models. Adalta is currently working to further develop AD-712 and bring it through clinical trials to evaluate its safety and efficacy in humans.Overall, AD-712 represents a promising new approach to the treatment of glioblastoma and may provide hope for patients with this devastating disease."
I suspect that it is referring to this collaboration. The molecule has a name and a purpose. That's something!
- Forums
- ASX - By Stock
- Ann: 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
I was playing with ChatGPT and asked it about Adalta Ltd. It...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.08M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.7¢ | $405 | 15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1187032 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 737562 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1187032 | 0.025 |
4 | 934357 | 0.024 |
1 | 100000 | 0.023 |
4 | 250450 | 0.022 |
2 | 1047615 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 437562 | 2 |
0.028 | 25000 | 1 |
0.029 | 92629 | 3 |
0.030 | 220875 | 2 |
0.032 | 230000 | 1 |
Last trade - 10.00am 04/06/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online